| Dr Robert N Gallinaro, MD | |
|
1541 Sw 1st Ave, Suite 105, Ocala, FL 34471-6506 | |
| (352) 622-8152 | |
| (352) 622-4408 |
| Full Name | Dr Robert N Gallinaro |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 36 Years |
| Location | 1541 Sw 1st Ave, Ocala, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538107909 | NPI | - | NPPES |
| 020023862 | Other | FL | MEDICARE RAILROAD |
| 375464200 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | ME0066386 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Ocala | Ocala, FL | Hospital |
| Marion Communtiy Hospital | Ocala, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Hospital Physician Group Inc | 2365679057 | 546 |
News Archive
The Justice Department on Wednesday chose a special master to administer a multibillion-dollar fund created to provide compensation to rescue workers and others sickened from exposure to toxic fumes, dust and smoke from ground zero after the 2001 terrorist attack.
Researchers have demonstrated the ability to deliver a fully functional copy of the CLN3 gene to stem cells of patients with juvenile NCL, an inherited neurodegenerative disease in which a mutation in the CLN3 gene causes early-onset severe central vision loss.
Scientists are hopeful that a new drug - called EIDD-2801 - could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.
Results of an Electronic Health Record (EHR) study assessing the most commonly used medications for raising blood pressure in patients with nontraumatic subarachnoid hemorrhage (SAH), a rare type of stroke, have been published in Neurosurgical Focus by scientists at The University of Texas Health Science Center at Houston (UTHealth).
› Verified 9 days ago
| Entity Name | Florida Hospital Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174955256 PECOS PAC ID: 2365679057 Enrollment ID: O20131231000600 |
News Archive
The Justice Department on Wednesday chose a special master to administer a multibillion-dollar fund created to provide compensation to rescue workers and others sickened from exposure to toxic fumes, dust and smoke from ground zero after the 2001 terrorist attack.
Researchers have demonstrated the ability to deliver a fully functional copy of the CLN3 gene to stem cells of patients with juvenile NCL, an inherited neurodegenerative disease in which a mutation in the CLN3 gene causes early-onset severe central vision loss.
Scientists are hopeful that a new drug - called EIDD-2801 - could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.
Results of an Electronic Health Record (EHR) study assessing the most commonly used medications for raising blood pressure in patients with nontraumatic subarachnoid hemorrhage (SAH), a rare type of stroke, have been published in Neurosurgical Focus by scientists at The University of Texas Health Science Center at Houston (UTHealth).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert N Gallinaro, MD 1541 Sw 1st Ave, Suite 105, Ocala, FL 34471-6506 Ph: (352) 622-8152 | Dr Robert N Gallinaro, MD 1541 Sw 1st Ave, Suite 105, Ocala, FL 34471-6506 Ph: (352) 622-8152 |
News Archive
The Justice Department on Wednesday chose a special master to administer a multibillion-dollar fund created to provide compensation to rescue workers and others sickened from exposure to toxic fumes, dust and smoke from ground zero after the 2001 terrorist attack.
Researchers have demonstrated the ability to deliver a fully functional copy of the CLN3 gene to stem cells of patients with juvenile NCL, an inherited neurodegenerative disease in which a mutation in the CLN3 gene causes early-onset severe central vision loss.
Scientists are hopeful that a new drug - called EIDD-2801 - could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.
Results of an Electronic Health Record (EHR) study assessing the most commonly used medications for raising blood pressure in patients with nontraumatic subarachnoid hemorrhage (SAH), a rare type of stroke, have been published in Neurosurgical Focus by scientists at The University of Texas Health Science Center at Houston (UTHealth).
› Verified 9 days ago
Kevin Marcell Hoddinott, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1511 Sw 1st Ave, Ocala, FL 34471 Phone: 352-368-1661 Fax: 352-867-9794 | |
Krishnaswamy Swaminathan, M.D Surgery Medicare: Accepting Medicare Assignments Practice Location: 1054 Sw 1st Ave, Ocala, FL 34474 Phone: 352-732-3036 Fax: 352-368-3940 | |
Dr. Nandkumar R Karve, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2091 Sw 55th Street Rd, Ocala, FL 34474 Phone: 352-237-3084 Fax: 352-237-3084 | |
Dr. Dwight D Landmann, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1541 Sw 1st Ave, Suite 105, Ocala, FL 34471 Phone: 352-622-8152 Fax: 352-622-4408 | |
Dr. Abdul Jabbar Barhoush, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1054 Sw 1st Ave, Ocala, FL 34474 Phone: 352-732-3036 Fax: 352-368-3940 | |
Amanda Michelle Burns, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1901 Se 18th Ave Ste 200, Ocala, FL 34471 Phone: 352-671-1202 Fax: 352-671-1154 | |
Mr. Christian O Oraedu, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1830 Se 18th Ave, Ste 3, Ocala, FL 34471 Phone: 352-690-6000 Fax: 352-690-6643 |